Abstract
The broad and potent activity of 2-thioxo-imidazolidin-4-one (2-thiohydantoin) has established it as one of the biologically important scaffolds. This article highlights the medicinal chemistry investigations in search for novel 2- thioxo-imidazolidin-4-one derivatives with promising biological activities. New 2-thioxo-imidazolidin-4-one derivatives contain diaryl, triaryl, pyrimidine, cycloalkylamines and glucopyranosyl substituents and their aryl and halogen and alkyl derivatives, and other substituent with varied the monocyclic (thiadiazole, sulfadiazole) heterocycles linked directly or through alkyl chain with the imidazolidine nucleus. Recently obtained 2-thioxo-imidazolidin-4-one derivatives exhibit promising antibacterial, antifungal, anticancer, anti-inflammatory and many more biological activities. This review shows current tendency in the 2-thioxo-imidazolidin-4-one synthesis and reveals the 2-thioxo-imidazolidin-4-one core to be potent pharmacophoric moiety.
Keywords: medicinal chemistry, biologically active heterocyclic compounds, scaffold, thiocarbonyl group, antithyroidal, Cterminal protein sequencing, antimicrobial, Cterminal protein sequencing [, human immunodeficiency virus (HIV), anti-ulcer and anti-inflammatory agents
Letters in Drug Design & Discovery
Title:A Study on the Biological Activity of 2-thioxo-imidazolidin-4-ones
Volume: 9 Issue: 5
Author(s): Sudha Vengurlekar, Rajesh Sharma, Piyush Trivedi
Affiliation:
Keywords: medicinal chemistry, biologically active heterocyclic compounds, scaffold, thiocarbonyl group, antithyroidal, Cterminal protein sequencing, antimicrobial, Cterminal protein sequencing [, human immunodeficiency virus (HIV), anti-ulcer and anti-inflammatory agents
Abstract: The broad and potent activity of 2-thioxo-imidazolidin-4-one (2-thiohydantoin) has established it as one of the biologically important scaffolds. This article highlights the medicinal chemistry investigations in search for novel 2- thioxo-imidazolidin-4-one derivatives with promising biological activities. New 2-thioxo-imidazolidin-4-one derivatives contain diaryl, triaryl, pyrimidine, cycloalkylamines and glucopyranosyl substituents and their aryl and halogen and alkyl derivatives, and other substituent with varied the monocyclic (thiadiazole, sulfadiazole) heterocycles linked directly or through alkyl chain with the imidazolidine nucleus. Recently obtained 2-thioxo-imidazolidin-4-one derivatives exhibit promising antibacterial, antifungal, anticancer, anti-inflammatory and many more biological activities. This review shows current tendency in the 2-thioxo-imidazolidin-4-one synthesis and reveals the 2-thioxo-imidazolidin-4-one core to be potent pharmacophoric moiety.
Export Options
About this article
Cite this article as:
Sudha Vengurlekar, Rajesh Sharma, Piyush Trivedi , A Study on the Biological Activity of 2-thioxo-imidazolidin-4-ones, Letters in Drug Design & Discovery 2012; 9 (5) . https://dx.doi.org/10.2174/157018012800389322
DOI https://dx.doi.org/10.2174/157018012800389322 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Biosensor Detection of COVID-19 in Lung Cancer: Hedgehog and Mucin
Signaling Insights
Current Pharmaceutical Design A Comparative Study of the Cytotoxic and Pro-apoptotic Properties of Nepeta binaloudensis
Letters in Drug Design & Discovery Editorial (Metastases Prevention is the Cure)
Current Cancer Therapy Reviews Combined Treatment with JFKD and Gefitinib Overcomes Drug Resistance in Non-Small Cell Lung Cancer
Current Pharmaceutical Biotechnology Oligonucleotides and G-quadruplex Stabilizers: Targeting Telomeres and Telomerase in Cancer Therapy
Current Pharmaceutical Design Is There a Role for Cytokine Based Therapies in Fibromyalgia
Current Pharmaceutical Design 2D, 3D, G-QSAR and Docking Studies of Thiazolyl-pyrazoline Analogues as Potent (Epidermal Growth Factor Receptor-tyrosine Kinase) EGFR-TK Inhibitors
Letters in Drug Design & Discovery Molecular and Biological Functions of Melatonin in Endometrial Cancer
Current Drug Targets Terpyridines and their Complexes with First Row Transition Metal Ions:Cytotoxicity, Nuclease Activity and Self-Assembly of Biomacromolecules
Current Topics in Medicinal Chemistry IFN-γ: Detection and Prevention of Release
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Targeting Established Tumor Vasculature: A Novel Approach to Cancer Treatment
Current Cancer Therapy Reviews Antibody Gene Therapy: Getting Closer to Clinical Application?
Current Gene Therapy Liposomal Doxorubicin Delivery Systems: Effects of Formulation and Processing Parameters on Drug Loading and Release Behavior
Current Drug Delivery Synthesis, Cytotoxicity, Antioxidant and Antimicrobial Activity of Indole Based Novel Small Molecules
Letters in Drug Design & Discovery Malignant Hypercalcemia
Current Medicinal Chemistry Candida Infections and Human Defensins
Protein & Peptide Letters Cardiotonic Steroids in Adaptation to Dietary Salt Intake
Current Clinical Pharmacology Perspectives on Chemopreventive and Therapeutic Potential of Curcumin Analogs in Medicinal Chemistry
Mini-Reviews in Medicinal Chemistry False Positive of <sup>68</sup>Ga-DOTATATE PET-CT in a Paraganglioma
Endocrine, Metabolic & Immune Disorders - Drug Targets Current Advances in Retroviral Gene Therapy
Current Gene Therapy